Johnson & Johnson(JNJ) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Nov 13 at 7:05 AM ET (Korea 11/13 21:05)AI-drawn chart patterns are for reference only.
Full metrics table
| Index | DJIA, S&P 500, RUI | P/E | 43.01 | EPS (ttm) | 6.59 | Insider Own | 0.12% | Shs Outstand | 2.41B | Perf Week | 4.11% |
| Market Cap | 682.52B | Forward P/E | 24.46 | EPS next Y | 4.31% | Insider Trans | -8.53% | Shs Float | 2.40B | Perf Month | 11.66% |
| Enterprise Value | 709.94B | PEG | 2.75 | EPS next Q | 2.91 | Inst Own | 77.43% | Short Float | 0.71% | Perf Quarter | 8.9% |
| Income | 16.09B | P/S | 6.87 | EPS this Y | 3% | Inst Trans | - | Short Ratio | 2.45 | Perf Half Y | 22.84% |
| Sales | 99.35B | P/B | 8.37 | EPS next 5Y | 8.89% | ROA | 8.25% | Short Interest | 17.07M | Perf YTD | 37% |
| Book/sh | 33.87 | P/C | 39.62 | EPS past 3/5Y | 17.88% 14.9% | ROE | 20.02% | 52W High | 0.1% ($283.25) | Perf Year | 45.85% |
| Cash/sh | 7.16 | P/FCF | 33.15 | Sales past 3/5Y | 5.56% 2.67% | ROIC | 13.72% | 52W Low | 46.85% ($193.07) | Perf 3Y | 92.54% |
| Dividend Est. | $5.34 (1.88%) | EV/EBITDA | 21.02 | EPS Y/Y TTM | -35.95% | Gross Margin | 67.65% | Volatility(W/M) | 2.27% 2.42% | Perf 5Y | 71.82% |
| Dividend TTM | 5.28 | EV/Sales | 7.15 | Sales Y/Y TTM | 7.81% | Oper. Margin | 25.85% | ATR (14) | 6.84 | Perf 10Y | 139.32% |
| Dividend Ex-Date | 2026/11/24 | Quick Ratio | 0.74 | EPS Q/Q | -95.96% | Profit Margin | 16.2% | RSI (14) | 63.97 | Recom | 1.93 |
| Dividend Gr. 3/5Y | 4.92% 5.25% | Current Ratio | 1.02 | Sales Q/Q | 5.87% | SMA20 | 4.99% ($270.04) | Beta | 0.2 | Target Price | $283.67 |
| Payout | 46.59% | Debt/Eq | 0.55 | Earnings | 2026/10/13 | SMA50 | 6.3% ($266.72) | Rel Volume | 1.26 | Prev Close | $280.41 |
| Employees | 140800 | LT Debt/Eq | 0.44 | EPS/Sales Surpr. | 2.68% 0.06% | SMA200 | 13.64% ($249.49) | Avg Volume(3M) | 6.97M | Price | $283.52 |
| IPO | 1944/9/25 | Option/Short | Yes/Yes | Trades | 111665 | Volume | 8,806,545 | Change | 1.11% |
💊 A global diversified healthcare company operating a two-pillar business structure of innovative pharmaceuticals and medtech (medical devices). Founded in 1886 in New Jersey, USA, it has expanded across the pharmaceuticals and medical devices sectors throughout its long history, and has established itself as a representative US dividend growth stock included in the Dow Jones Industrial Average.
Over the past 1 year, on the higher side
0% below its 1-year high.
Traded more than usual. That is 126% of its average volume.
Ex-dividend date: November 24
11 days to go. Buy before this date to receive the dividend.
JNJ makes money exceptionally well
Of every $100 in sales, $25.85 is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by +3.0% this year.
Tap to view numbers
However, it looks expensive
Counting its debt, for $100 of yearly operating cash you would pay $2,102. Peers typically go for $1,498. Compared with its own 5-year average, it is 82% pricier now.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +71.8%. The S&P 500 did +62% over the same period.
Tap to view numbers
The dividend is on the small side
Pays 1.88% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 77.4%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It ranks #2 of 21 in the industry
Based on market cap of $683B.
LLY#1 Lilly(Eli) & Co $1.3T PER 46.9 
JNJ#2 Johnson & Johnson $683B PER 43.0 
ABBV#3 Abbvie Inc $520B PER 50.7 
MRK#4 Merck & Co Inc $362B PER 150.1 
NVS#5 Novartis AG ADR $293B PER 30.6 
FAQ
What kind of company is JNJ?
JNJ belongs to the Healthcare sector and operates in the Drug Manufacturers - General industry.
What is the market cap of JNJ?
The market cap of JNJ is approximately $682.5B, ranking 22 within its sector.
Does JNJ pay dividends?
JNJ has a dividend yield of approximately 1.88%, with an annual dividend of $5.34.
What is the P/E ratio of JNJ?
JNJ has a P/E ratio of approximately 43.0x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for JNJ?
JNJ has recorded a 52-week high of $283.25 and a low of $193.07.
